Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Frederic Colombel

Showing results (231-240 of 462) with videos related to

Pageof 47
Sort By:
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2016
Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical TrialsEdward V Loftus, Jean-Frederic Colombel, Stefan Schreiber, et al.
Journal of Crohn'S & Colitis|February 16, 2026
Tunnel vision: Rethinking local therapy for perianal fistulas in Crohn's diseaseMaria Manuela Estevinho, Eathar Shakweh, WonKyung Cho, et al.
Journal of Crohn'S & Colitis|February 13, 2019
Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease StudiesRemo Panaccione, Robert Löfberg, Paul Rutgeerts, et al.
Inflammatory Bowel Diseases|January 9, 2007
Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified)Vincent Maunoury, Guillaume Savoye, Arnaud Bourreille, et al.
Journal of Crohn'S & Colitis|February 17, 2024
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled TrialWalter Reinisch, Jean-Frederic Colombel, Geert R D'Haens, et al.
Gastro Hep Advances|August 12, 2024
Development of a Novel Ulcerative Colitis Endoscopic Mayo Score Prediction Model Using Machine LearningDavid T Rubin, Klaus Gottlieb, Jean-Frederic Colombel, et al.
Gastroenterology|December 31, 2003
The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patientsJean-Frederic Colombel, Edward V Loftus, William J Tremaine, et al.
Annals of the Rheumatic Diseases|January 25, 2019
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trialsStefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2014
Factors associated with short- and long-term outcomes of therapy for Crohn's diseaseWalter Reinisch, Jean-Frederic Colombel, William J Sandborn, et al.
Gut|July 24, 2014
Intestinal steroidogenesis controls PPARγ expression in the colon and is impaired during ulcerative colitisGuillaume Bouguen, Audrey Langlois, Madjid Djouina, et al.
Pageof 47

Showing results (231-240 of 462) with videos related to

Sort By:
Pageof 47
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 29, 2016
Safety of Long-term Treatment With Certolizumab Pegol in Patients With Crohn's Disease, Based on a Pooled Analysis of Data From Clinical TrialsEdward V Loftus, Jean-Frederic Colombel, Stefan Schreiber, et al.
Journal of Crohn'S & Colitis|February 16, 2026
Tunnel vision: Rethinking local therapy for perianal fistulas in Crohn's diseaseMaria Manuela Estevinho, Eathar Shakweh, WonKyung Cho, et al.
Journal of Crohn'S & Colitis|February 13, 2019
Efficacy and Safety of Adalimumab by Disease Duration: Analysis of Pooled Data From Crohn's Disease StudiesRemo Panaccione, Robert Löfberg, Paul Rutgeerts, et al.
Inflammatory Bowel Diseases|January 9, 2007
Value of wireless capsule endoscopy in patients with indeterminate colitis (inflammatory bowel disease type unclassified)Vincent Maunoury, Guillaume Savoye, Arnaud Bourreille, et al.
Journal of Crohn'S & Colitis|February 17, 2024
Efficacy and Safety of Filgotinib for the Treatment of Perianal Fistulising Crohn's Disease [DIVERGENCE 2]: A Phase 2, Randomised, Placebo-controlled TrialWalter Reinisch, Jean-Frederic Colombel, Geert R D'Haens, et al.
Gastro Hep Advances|August 12, 2024
Development of a Novel Ulcerative Colitis Endoscopic Mayo Score Prediction Model Using Machine LearningDavid T Rubin, Klaus Gottlieb, Jean-Frederic Colombel, et al.
Gastroenterology|December 31, 2003
The safety profile of infliximab in patients with Crohn's disease: the Mayo clinic experience in 500 patientsJean-Frederic Colombel, Edward V Loftus, William J Tremaine, et al.
Annals of the Rheumatic Diseases|January 25, 2019
Incidence rates of inflammatory bowel disease in patients with psoriasis, psoriatic arthritis and ankylosing spondylitis treated with secukinumab: a retrospective analysis of pooled data from 21 clinical trialsStefan Schreiber, Jean-Frederic Colombel, Brian G Feagan, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 24, 2014
Factors associated with short- and long-term outcomes of therapy for Crohn's diseaseWalter Reinisch, Jean-Frederic Colombel, William J Sandborn, et al.
Gut|July 24, 2014
Intestinal steroidogenesis controls PPARγ expression in the colon and is impaired during ulcerative colitisGuillaume Bouguen, Audrey Langlois, Madjid Djouina, et al.
Pageof 47